Home » News » Awards & Advancement » Oncobiologics names Canute to board of directors

Oncobiologics names Canute to board of directors

Wednesday, October 12, 2011

Oncobiologics has named Scott Canute to its board of directors.

Over the course of his 30-year career, Canute played a vital role in leading Eli Lilly’s global manufacturing operations.  Most recently, he spent more than a year as president of global manufacturing and corporate operations for Genzyme.

“Scott Canute has been a distinguished leader at major biopharmaceutical organizations throughout his career,” said Oncobiologics founder & CEO Pankaj Mohan, Ph.D.  “I have known and admired Scott as my mentor for many years, and I am honored that he will share his experience and strategic insight to our efforts at Oncobiologics.  We look forward to guidance from Scott as a member of our board.”

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!